{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:26:41Z","timestamp":1785403601201,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"19-20","license":[{"start":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T00:00:00Z","timestamp":1470700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000839","name":"University of Reading","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00213-016-4397-4","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T02:24:03Z","timestamp":1470709443000},"page":"3603-3613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats"],"prefix":"10.1007","volume":"233","author":[{"given":"Daniel I","family":"Brierley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marnie","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J","family":"Whalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,9]]},"reference":[{"key":"4397_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00213-015-4100-1","volume":"233","author":"DI Brierley","year":"2016","unstructured":"Brierley DI, Samuels J, Duncan M, Whalley BJ, Williams CM (2016) Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea. Psychopharmacology 233:243\u2013254. doi: 10.1007\/s00213-015-4100-1","journal-title":"Psychopharmacology"},{"key":"4397_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1476-5381.2009.00515.x","volume":"159","author":"MG Cascio","year":"2010","unstructured":"Cascio MG, Gauson LA, Stevenson LA, Ross RA, Pertwee RG (2010) Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. Br J Pharmacol 159:129\u2013141. doi: 10.1111\/j.1476-5381.2009.00515.x","journal-title":"Br J Pharmacol"},{"key":"4397_CR3","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","volume":"163","author":"L De Petrocellis","year":"2011","unstructured":"De Petrocellis L, Ligresti A, Moriello AS, Allar\u00e0 M, Bisogno T, Petrosino S, Stott CG, Di Marzo V (2011) Effects of cannabinoids and cannabinoid-enriched cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol 163:1479\u20131494. doi: 10.1111\/j.1476-5381.2010.01166.x","journal-title":"Br J Pharmacol"},{"key":"4397_CR4","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","volume":"219","author":"S Deiana","year":"2012","unstructured":"Deiana S, Watanabe A, Yamasaki Y, Amada N, Arthur M, Fleming S, Woodcock H, Dorward P, Pigliacampo B, Close S, Platt B, Riedel G (2012) Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), \u03949-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behavi. Psychopharmacology 219:859\u2013873. doi: 10.1007\/s00213-011-2415-0","journal-title":"Psychopharmacology"},{"key":"4397_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1517\/14740338.2012.675326","volume":"11","author":"G Derosa","year":"2012","unstructured":"Derosa G, Maffioli P (2012) Anti-obesity drugs: a review about their effects and their safety. Expert Opin Drug Saf 11:459\u2013471. doi: 10.1517\/14740338.2012.675326","journal-title":"Expert Opin Drug Saf"},{"key":"4397_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nn1457","volume":"8","author":"V Di Marzo","year":"2005","unstructured":"Di Marzo V, Matias I (2005) Endocannabinoid control of food intake and energy balance. Nat Neurosci 8:585\u2013589. doi: 10.1038\/nn1457","journal-title":"Nat Neurosci"},{"key":"4397_CR7","doi-asserted-by":"publisher","unstructured":"Di Marzo V, Piscitelli F, Mechoulam R (2011) Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. Handb Exp Pharmacol:75\u2013104. doi: 10.1007\/978-3-642-17214-4_4","DOI":"10.1007\/978-3-642-17214-4_4"},{"key":"4397_CR8","first-page":"272","volume-title":"Pharmacological properties of pure cannabigerol and cannabigerol botanical drug substance. 24th Annu","author":"M Duncan","year":"2014","unstructured":"Duncan M, Cascio MG, Pertwee R, Reidel G, Amada N, Yamasaki Y (2014) Pharmacological properties of pure cannabigerol and cannabigerol botanical drug substance. 24th Annu. Symp. Cannabinoids. International Cannabinoid Research Society, Research Triangle Park, Durham, p. 272"},{"key":"4397_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.pbb.2010.03.004","volume":"95","author":"AT El-Alfy","year":"2010","unstructured":"El-Alfy AT, Ivey K, Robinson K, Ahmed S, Radwan M, Slade D, Khan I, ElSohly M, Ross S (2010) Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. Pharmacol Biochem Behav 95:434\u2013442. doi: 10.1016\/j.pbb.2010.03.004","journal-title":"Pharmacol Biochem Behav"},{"key":"4397_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","volume":"78","author":"MA Elsohly","year":"2005","unstructured":"Elsohly MA, Slade D (2005) Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci 78:539\u2013548. doi: 10.1016\/j.lfs.2005.09.011","journal-title":"Life Sci"},{"key":"4397_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00213-010-1821-z","volume":"210","author":"JA Farrimond","year":"2010","unstructured":"Farrimond JA, Hill AJ, Whalley BJ, Williams CM (2010a) Cannabis constituents modulate \u03b49-tetrahydrocannabinol-induced hyperphagia in rats. Psychopharmacology 210:97\u2013106. doi: 10.1007\/s00213-010-1821-z","journal-title":"Psychopharmacology"},{"key":"4397_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e328340a062","author":"JA Farrimond","year":"2010","unstructured":"Farrimond JA, Whalley BJ, Williams CM (2010b) A low-\u03949tetrahydrocannabinol cannabis extract induces hyperphagia in rats. Behav Pharmacol. doi: 10.1097\/FBP.0b013e328340a062","journal-title":"Behav Pharmacol"},{"key":"4397_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/FBP.0b013e32834ed832","volume":"23","author":"JA Farrimond","year":"2012","unstructured":"Farrimond JA, Whalley BJ, Williams CM (2012a) Non-\u03949tetrahydrocannabinol phytocannabinoids stimulate feeding in rats. Behav Pharmacol 23:113\u2013117. doi: 10.1097\/FBP.0b013e32834ed832","journal-title":"Behav Pharmacol"},{"key":"4397_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00213-012-2697-x","volume":"223","author":"JA Farrimond","year":"2012","unstructured":"Farrimond JA, Whalley BJ, Williams CM (2012b) Cannabinol and cannabidiol exert opposing effects on rat feeding patterns. Psychopharmacology 223:117\u2013129. doi: 10.1007\/s00213-012-2697-x","journal-title":"Psychopharmacology"},{"key":"4397_CR15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/ja00730a036","volume":"93","author":"Y Gaoni","year":"1971","unstructured":"Gaoni Y, Mechoulam R (1971) The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. J Am Chem Soc 93:217\u2013224","journal-title":"J Am Chem Soc"},{"key":"4397_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2174\/1389450043490541","volume":"5","author":"JCG Halford","year":"2004","unstructured":"Halford JCG, Cooper GD, Dovey TM (2004) The pharmacology of human appetite expression. Curr Drug Targets 5:221\u2013240. doi: 10.2174\/1389450043490541","journal-title":"Curr Drug Targets"},{"key":"4397_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pharmthera.2011.09.002","volume":"133","author":"AJ Hill","year":"2012","unstructured":"Hill AJ, Williams CM, Whalley BJ, Stephens GJ (2012a) Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacol Ther 133:79\u201397. doi: 10.1016\/j.pharmthera.2011.09.002","journal-title":"Pharmacol Ther"},{"key":"4397_CR18","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1111\/j.1476-5381.2012.02207.x","volume":"167","author":"AJ Hill","year":"2012","unstructured":"Hill AJ, Mercier MS, Hill TDM, Glyn SE, Jones NA, Yamasaki Y, Futamura T, Duncan M, Stott CG, Stephens GJ, Williams CM, Whalley BJ (2012b) Cannabidivarin is anticonvulsant in mouse and rat. Br J Pharmacol 167:1629\u20131642. doi: 10.1111\/j.1476-5381.2012.02207.x","journal-title":"Br J Pharmacol"},{"key":"4397_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/bph.12321","volume":"170","author":"TDM Hill","year":"2013","unstructured":"Hill TDM, Cascio M-G, Romano B, Duncan M, Pertwee RG, Williams CM, Whalley BJ, Hill AJ (2013) Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. Br J Pharmacol 170:679\u2013692. doi: 10.1111\/bph.12321","journal-title":"Br J Pharmacol"},{"key":"4397_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.neulet.2014.03.013","volume":"566","author":"AJ Hill","year":"2014","unstructured":"Hill AJ, Jones NA, Smith I, Hill CL, Williams CM, Stephens GJ, Whalley BJ (2014) Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se. Neurosci Lett 566:269\u2013274. doi: 10.1016\/j.neulet.2014.03.013","journal-title":"Neurosci Lett"},{"key":"4397_CR21","doi-asserted-by":"publisher","DOI":"10.1242\/bio.20149571","author":"NA Hofmann","year":"2014","unstructured":"Hofmann NA, Barth S, Waldeck-Weiermair M, Klec C, Strunk D, Malli R, Graier WF (2014) TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation. Biol Open. doi: 10.1242\/bio.20149571","journal-title":"Biol Open"},{"key":"4397_CR22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cpt197112144","volume":"12","author":"LE Hollister","year":"1971","unstructured":"Hollister LE (1971) Hunger and appetite after single doses of marihuana, alcohol, and dextroamphetamine. Clin Pharmacol Ther 12:44\u201349","journal-title":"Clin Pharmacol Ther"},{"key":"4397_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1200\/JCO.20.2.567","volume":"20","author":"A Jatoi","year":"2002","unstructured":"Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, Pundaleeka S, Kardinal CG, Fitch TR, Krook JE, Novotny PJ, Christensen B (2002) Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a north central cancer treatment group study. J Clin Oncol 20:567\u2013573. doi: 10.1200\/JCO.20.2.567","journal-title":"J Clin Oncol"},{"key":"4397_CR24","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","volume":"160","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010) Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160:1577\u20131579. doi: 10.1111\/j.1476-5381.2010.00872.x","journal-title":"Br J Pharmacol"},{"key":"4397_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","volume":"136","author":"TC Kirkham","year":"2002","unstructured":"Kirkham TC, Williams CM, Fezza F, Di Marzo V (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136:550\u2013557. doi: 10.1038\/sj.bjp.0704767","journal-title":"Br J Pharmacol"},{"key":"4397_CR26","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1096\/fj.14-268300","volume":"29","author":"E Lee","year":"2015","unstructured":"Lee E, Jung DY, Kim JH, Patel PR, Hu X, Lee Y, Azuma Y, Wang H-F, Tsitsilianos N, Shafiq U, Kwon JY, Lee HJ, Lee KW, Kim JK (2015) Transient receptor potential vanilloid type-1 channel regulates diet-induced obesity, insulin resistance, and leptin resistance. FASEB J 29:3182\u20133192. doi: 10.1096\/fj.14-268300","journal-title":"FASEB J"},{"key":"4397_CR27","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1017\/S1461145709990605","volume":"13","author":"LE Long","year":"2010","unstructured":"Long LE, Chesworth R, Huang X-F, McGregor IS, Arnold JC, Karl T (2010) A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL\/6JArc mice. Int J Neuropsychopharmacol 13:861\u2013876. doi: 10.1017\/S1461145709990605","journal-title":"Int J Neuropsychopharmacol"},{"key":"4397_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bbr.2010.03.046","volume":"212","author":"SS Mansur","year":"2010","unstructured":"Mansur SS, Terenzi MG, Neto JM, Faria MS, Paschoalini MA (2010) Changes in food intake and anxiety-like behaviors after clonidine injected into the median raphe nucleus. Behav Brain Res 212:71\u201377. doi: 10.1016\/j.bbr.2010.03.046","journal-title":"Behav Brain Res"},{"key":"4397_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0091-3057(94)90475-8","volume":"49","author":"RD Mattes","year":"1994","unstructured":"Mattes RD, Engelman K, Shaw LM, Elsohly MA (1994) Cannabinoids and appetite stimulation. Pharmacol Biochem Behav 49:187\u2013195. doi: 10.1016\/0091-3057(94)90475-8","journal-title":"Pharmacol Biochem Behav"},{"key":"4397_CR30","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","volume":"160","author":"JC McGrath","year":"2010","unstructured":"McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL (2010) Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160:1573\u20131576. doi: 10.1111\/j.1476-5381.2010.00873.x","journal-title":"Br J Pharmacol"},{"key":"4397_CR31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0040-4020(65)80064-3","volume":"21","author":"R Mechoulam","year":"1965","unstructured":"Mechoulam R, Gaoni Y (1965) Hashish IV. The isolation and structure of cannabinolic cannabidiolic and cannabigerolic acids. Tetrahedron 21:1223\u20131229","journal-title":"Tetrahedron"},{"key":"4397_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-3084(00)00184-5","volume":"108","author":"R Mechoulam","year":"2000","unstructured":"Mechoulam R, Hanus L (2000) A historical overview of chemical research on cannabinoids. Chem Phys Lipids 108:1\u201313. doi: 10.1016\/S0009-3084(00)00184-5","journal-title":"Chem Phys Lipids"},{"key":"4397_CR33","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.169.3945.611","volume":"169","author":"R Mechoulam","year":"1970","unstructured":"Mechoulam R, Shani A, Edery H, Grunfeld Y (1970) Chemical basis of hashish activity. Science 169:611\u2013612","journal-title":"Science"},{"key":"4397_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0091-3057(93)90241-K","volume":"45","author":"M Navarro","year":"1993","unstructured":"Navarro M, Fern\u00e1ndez-Ruiz JJ, De Miguel R, Hern\u00e1ndez ML, Cebeira M, Ramos JA (1993) Motor disturbances induced by an acute dose of delta 9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations. Pharmacol Biochem Behav 45:291\u2013298. doi: 10.1016\/0091-3057(93)90241-K","journal-title":"Pharmacol Biochem Behav"},{"key":"4397_CR35","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.pbb.2012.10.008","volume":"103","author":"LD O\u2019Brien","year":"2013","unstructured":"O\u2019Brien LD, Wills KL, Segsworth B, Dashney B, Rock EM, Limebeer CL, Parker LA (2013) Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. Pharmacol Biochem Behav 103:597\u2013602. doi: 10.1016\/j.pbb.2012.10.008","journal-title":"Pharmacol Biochem Behav"},{"key":"4397_CR36","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","volume":"62","author":"RG Pertwee","year":"2010","unstructured":"Pertwee RG, Howlett AC, Abood ME, Alexander SPH, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA (2010) International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 62:588\u2013631. doi: 10.1124\/pr.110.003004","journal-title":"Pharmacol Rev"},{"key":"4397_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3\u201333. doi: 10.1016\/S0014-2999(03)01272-X","journal-title":"Eur J Pharmacol"},{"key":"4397_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbb.2011.11.011","volume":"101","author":"C Reyes-Cabello","year":"2012","unstructured":"Reyes-Cabello C, Alen F, G\u00f3mez R, Serrano A, Rivera P, Orio L, Rodr\u00edguez de Fonseca F, Pav\u00f3n FJ (2012) Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration. Pharmacol Biochem Behav 101:1\u20137. doi: 10.1016\/j.pbb.2011.11.011","journal-title":"Pharmacol Biochem Behav"},{"key":"4397_CR39","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.physbeh.2011.08.028","volume":"105","author":"AS Ribas","year":"2012","unstructured":"Ribas AS, Flores RA, de Nazareth AM, Faria MS, Terenzi MG, Marino-Neto J, Paschoalini MA (2012) Feeding behaviour after injection of \u03b1-adrenergic receptor agonists into the median raphe nucleus of food-deprived rats. Physiol Behav 105:220\u2013229. doi: 10.1016\/j.physbeh.2011.08.028","journal-title":"Physiol Behav"},{"key":"4397_CR40","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1200\/JCO.2005.05.1847","volume":"24","author":"F Strasser","year":"2006","unstructured":"Strasser F, Luftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, Ko Y-D, Schnelle M, Reif M, Cerny T (2006) Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabi. J Clin Oncol 24:3394\u20133400. doi: 10.1200\/JCO.2005.05.1847","journal-title":"J Clin Oncol"},{"key":"4397_CR41","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1476-5381.2011.01484.x","volume":"164","author":"BG Taksande","year":"2011","unstructured":"Taksande BG, Kotagale NR, Nakhate KT, Mali PD, Kokare DM, Hirani K, Subhedar NK, Chopde CT, Ugale RR (2011) Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y. Br J Pharmacol 164:704\u2013718. doi: 10.1111\/j.1476-5381.2011.01484.x","journal-title":"Br J Pharmacol"},{"key":"4397_CR42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.6004\/jnccn.2012.0048","volume":"10","author":"B Todaro","year":"2012","unstructured":"Todaro B (2012) Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting. J Natl Compr Cancer Netw 10:487\u2013492","journal-title":"J Natl Compr Cancer Netw"},{"key":"4397_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/0024-3205(93)90243-V","volume":"53","author":"PJ Wellman","year":"1993","unstructured":"Wellman PJ, Davies BT, Morien A, McMahon L (1993) Modulation of feeding by hypothalamic paraventricular nucleus alpha 1- and alpha 2-adrenergic receptors. Life Sci 53:669\u2013679. doi: 10.1016\/0024-3205(93)90243-V","journal-title":"Life Sci"},{"key":"4397_CR44","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002130050953","volume":"143","author":"CM Williams","year":"1999","unstructured":"Williams CM, Kirkham TC (1999) Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology 143:315\u2013317. doi: 10.1007\/s002130050953","journal-title":"Psychopharmacology"},{"key":"4397_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0031-9384(02)00725-4","volume":"76","author":"CM Williams","year":"2002","unstructured":"Williams CM, Kirkham TC (2002a) Observational analysis of feeding induced by delta9-THC and anandamide. Physiol Behav 76:241\u2013250. doi: 10.1016\/S0031-9384(02)00725-4","journal-title":"Physiol Behav"},{"key":"4397_CR46","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0091-3057(01)00694-3","volume":"71","author":"CM Williams","year":"2002","unstructured":"Williams CM, Kirkham TC (2002b) Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71:333\u2013340. doi: 10.1016\/S0091-3057(01)00694-3","journal-title":"Pharmacol Biochem Behav"},{"key":"4397_CR47","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0031-9384(98)00170-X","volume":"65","author":"CM Williams","year":"1998","unstructured":"Williams CM, Rogers PJ, Kirkham TC (1998) Hyperphagia in pre-fed rats following oral delta9-THC. Physiol Behav 65:343\u2013346. doi: 10.1016\/S0031-9384(98)00170-X","journal-title":"Physiol Behav"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4397-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-016-4397-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4397-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:14:53Z","timestamp":1498320893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-016-4397-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,9]]},"references-count":47,"journal-issue":{"issue":"19-20","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["4397"],"URL":"https:\/\/doi.org\/10.1007\/s00213-016-4397-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,9]]}}}